Home › Chronic Inflammatory Demyelinating Polyradiculoneuropathy › California
Chronic Inflammatory Demyelinating Polyradiculoneuropathy clinical trials in California
11 studies for Chronic Inflammatory Demyelinating Polyradiculoneuropathy are looking for participants at sites in California.
Cities in California
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Site Number - 1618, Carlsbad
- Site Number - 1637, Mission Hills
- Site Number - 1619, Orange
- and 2 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07032662A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
- Samir Macwan, M.D., Inc. (S corporation), Rancho Mirage
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07091630A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
- Samir Macwan, M.D., Inc., Rancho Mirage
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06920004A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Keck School of Medicine of University of Southern California- Site Number : 8400002, Los Angeles
- University of California Irvine Medical Center- Site Number : 8400007, Orange
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06290141A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
- TG Therapeutics Investigational Trial Site, La Jolla
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06680037A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- GC2402 Study Site 104, Rancho Mirage
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT07540221A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
- Clinical Study Site, Los Angeles
- Clinical Study Site, San Francisco
- Clinical Study Site, San Francisco
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 2, 2026 · NCT06858579A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases
- Hoag Memorial Hospital Presbyterian, Newport Beach
- Stanford Neuroscience Health Center, Palo Alto
RecruitingPhase 1
Ages 18 to 75 · All sexes · Updated Aug 14, 2026 · NCT07304154A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- University of California San Diego, La Jolla
- California Pacific Medical Center, San Francisco
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 23, 2026 · NCT06798012A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- Stanford Neuroscience Health Center, Palo Alto
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jan 20, 2026 · NCT06747351A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care
- Samir Macwan MD Inc, Rancho Mirage
- Neuro/Psych Sleep Clinic, San Francisco
RecruitingObservational study
Ages 18 and older · All sexes · Updated Nov 21, 2025 · NCT06538064From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.